M. M. de las Alas

A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel

S. Aebi, T. Schnider, S. Howell, 1999, Cancer Chemotherapy and Pharmacology.

Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance.

S. Aebi, G. Los, D. Fink, 1997, Journal of the National Cancer Institute.

Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanine.

S. Howell, Xinjian Lin, G. Los, 2002, Molecular pharmacology.

Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel

S. Aebi, S. Howell, G. Los, 2000, Cancer Chemotherapy and Pharmacology.